Skip to content

3M

US · MMM #265 by market cap Listed 1970
177.99 -0.48 -0.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:33

Valuation each multiple against its own 5-year range

P/B ratio 22.99 Expensive vs history 90th percentile
5-year average 12.46 · #26 of 27 in Conglomerates
P/E ratio 27.41 Expensive vs history 83rd percentile
5-year average 13.38 · forward 20.48 · #13 of 14 in Conglomerates
P/S ratio 3.57 Expensive vs history 95th percentile
5-year average 2.16 · forward 3.41 · #26 of 29 in Conglomerates

Vs. peers Conglomerates

Company Market cap P/E (TTM) P/B Div yield
3M (MMM) 91.97B 26.57 22.28 1.72%
Honeywell (HON) 67.48B 9.60 3.01 3.69%
Valmont Industries (VMI) 7.38B 14.35 4.19 0.78%
Brookfield Business Corp (BBUC) 5.67B -461.50 1.03 0.90%
Graham Holdings (GHC) 5.22B 11.02 1.09 0.59%
Seaboard (SEB) 3.50B 6.34 0.63 0.25%

Other StockVane-tracked companies in the same industry.

Morningstar

★★☆☆☆ Fair value125.00 Economic moatNarrow UncertaintyVery High Capital allocationStandard

Trading 29.8% above Morningstar's fair value estimate.

Analyst note

On Nov. 3, 3M announced it had agreed to settle 99% of existing personal injury claims caused by PFAS in aqueous firefighting foam by paying out $7.35 billion over the next nine years. It also created mechanisms to address future litigation.

The bottom line: We expect to maintain our $125 fair value estimate for narrow-moat 3M. We had already baked in around $5 billion in unannounced settlements on top of the $7.5 billion 3M previously accrued. We note that 3M still likely has years of PFAS-related lawsuits ahead of it. The agreement leaves meaningful unresolved categories, especially internationally. Although we expect to raise the present value of 3M’s PFAS settlements to account for these, we also believe that as settlement payments eventually decline, 3M could earn a lower cost of capital and regain the financial flexibility to reinvest in organic growth.

Fair value

Our $125 fair value estimate is roughly 14 times 3M’s 2026 adjusted earnings per share, which is a significant discount relative to the US multi-industrial category and 3M’s peers. We view this as reasonable, given the firm’s legal uncertainties and uninspiring growth profile.

We think 3M will increase its top line organically by around 3.5% over our long-term forecast, slightly above gross domestic product growth, since most of its markets are mature. Beyond share buybacks, we expect 3M to realize margin improvements from operating leverage and efficiency gains, driving mid-single-digit EPS growth over the long term.

In the coming decade, we think 3M can maintain excess returns on capital over its estimated cost of capital of around 8.0%. However, our confidence in 3M’s ability to generate excess returns over a multidecade horizon has declined substantially, as issues regarding PFAS could take decades to resolve. We remain confident in 3M’s liquidity to fund its dividend and no longer expect it to take on more debt during our explicit forecast. We think 3M will face nearly $12.5 billion in PFAS-related legal liabilities in a base-case scenario. 3M snapped its 64-year dividend-growth streak to fund legal settlements, and ensuing litigation could threaten future dividend payments.

We like 3M's higher-conviction bets, such as in automotive electrification where it derives significant advantages from spec-in projects with auto OEM customers. These bets are starting to pay off and should become more apparent as 3M continues to prune the softer parts of its portfolio, where it has limited reinvestment runway. We also think 3M's core businesses will continue pulling their weight, including personal protective equipment, industrial adhesives, automotive, and home improvement products. With 3M's current lineup, we expect the firm will increasingly direct its R&D and capital expenditures toward these divisions, which we believe can grow faster than GDP. Overall, the PPE market is driven by stricter employee health and safety regulations and increased manufacturing and construction activity in developing economies. In our view, the firm is well positioned in this segment given its brand strength and material science competency.

Economic moat

3M has a Morningstar Economic Moat Rating of narrow, primarily driven by intangible assets and a cost advantage. Our confidence in 3M’s ability to generate returns on invested capital above its cost of capital over a multidecade period has waned substantially in recent years. We believe 3M’s economic moat is weakening, as evidenced by declining gross margins, returns on capital, and organic volume growth. It also has substantial legal uncertainties regarding PFAS that could, in an unlikely but possible scenario, bankrupt the firm. On a stand-alone basis, each of 3M’s segments merits a narrow moat.

3M’s “secret sauce” is its centralized research and development apparatus. It has helped 3M create a stable of brands and proprietary technology. These intangibles give 3M pricing power; excluding electronics, 3M has historically raised its prices by 30-50 basis points above inflation. 3M also commands premium pricing over competing products, typically between 10% and 30%.

We believe 3M uses its manufacturing scale to achieve the lowest unit cost in most of the categories in which it competes. It invests heavily in R&D, averaging around 6% of sales. Although this figure has declined in recent decades, it is still markedly higher than the peer average of 3.5%. 3M has developed over 50 technology platforms that it leverages across its 60,000-product base. By using the same manufacturing assets across many product lines, 3M reduces the marginal cost of making an additional unit, giving it economies of scope. Examples of shared technologies include abrasives used in sanding discs, kitchen sponges, and headlight cleaners, and adhesives used in electrical tapes, Post-it notes, and cardboard bonding.

We believe 3M’s safety and industrial segment merits a narrow moat. Historically, this segment boasts midteens returns on invested capital. Within the segment, 3M’s abrasives division has carved out a narrow moat through brand strength (brands such as Scotch-Brite and Cubitron) and economies of scope. The firm pioneered abrasives innovations, including precision-shaped grains made possible by 3M’s microreplication technology.

The segment’s industrial adhesives and tapes and automotive aftermarket divisions follow the same formula of narrow moats derived from intangible assets and cost advantage. Each division has brands that leverage the same proprietary technologies 3M developed in-house, allowing 3M to generate economies of scope.

The narrow-moat closure and masking systems division sells packaging consumables and equipment. It installs this equipment into customer operations, creating switching costs.

The firm’s electrical markets division has no moat as it mostly sells commodity-like products such as heat-shrink tubing, wiring, and cable components. Electrical connectors for harsh environments are more differentiated, but they represent a small portion of the division.

We believe the segment’s only wide-moat division is personal safety, where 3M holds strong market share and a portfolio of brands such as Peltor and Speedglas. 3M dominates disposable respirators, fire safety, and fall protection equipment. High failure costs and regulatory hurdles give value to 3M’s time-tested brands.

We think the roofing granules division has a narrow moat from intangible assets and a cost advantage. 3M has participated in this market for over a century, and we believe its classic granules are the industry standard. 3M has developed numerous specialty granules, including smog-reducing and solar-reflective granules.

In 3M’s second narrow-moat business segment, transportation and electronics, we assign its advanced materials division a narrow moat driven by intangible assets and cost advantages. 3M's high R&D spending has produced differentiated composite resins, polymer additives, and magnetic sheets, among others.

We think the segment’s automotive and aerospace division has a narrow moat driven by intangible assets and cost advantages. We believe most of this division’s revenue comes from automotive products, which generally have weaker competitive advantages than plane parts.

3M’s narrow-moat commercial solutions division, which includes products such as antislip mats, fire barriers, and chemical sorbent pads, uses the same technologies as other divisions, such as films, tapes, and adhesives, giving rise to economies of scope.

3M’s transportation safety division manufactures reflective road signage and benefits from intangible assets and a cost advantage, creating a narrow moat. Road infrastructure is highly regulated, and 3M’s products play a critical role in ensuring motorist safety.

We believe the consumer segment has a narrow moat. 3M’s consumer businesses generate the company’s highest returns on invested capital, averaging in the mid- to high 20s, in line with high-performing peers such as Clorox and Kimberly-Clark. Within the segment, we think the home, health, and auto care division has a wide moat as it contains some of the firm’s strongest brands, such as Ace bandages and Scotch-Brite sponges, along with economies of scope and scale.

We assign 3M’s construction and home improvement division a narrow moat. Its brands include Scotch masking tape, Filtrete air filters, and Command hanging solutions. 3M leverages its adhesive technology into numerous products such as picture hangers, duct tape, and toilet paper holders.

The stationery and office division has a narrow but weakening moat; it earns strong returns, but incremental returns on invested capital should trend downward as the world becomes increasingly digital. Brands such as Post-it hold dominant global mindshare, but we believe private labels and consumer trade-down activity have eroded the pricing power of many 3M consumer products.

Bull case

3M’s legacy portfolio remains highly profitable and is poised to benefit from multiple secular growth trends, such as a growing global middle class and rising regulatory standards.

The firm’s asset utilization should improve as it works to cut excess operating costs and optimize production at underutilized manufacturing plants.

Costs associated with PFAS litigation are already baked into 3M’s share price, and any subsequent decline below our fair-value estimate could offer an attractive entry point.

Bear case

Multibillion-dollar pending litigation risks will cripple the value of the company and remove any benefit from potential fundamental catalysts.

Management has indicated that the company plans to sell through more distributors, which could increase customer concentration, increase the distance from the end customer (thereby stifling innovation), and reduce margins.

Without its healthcare segment, 3M will grow far more slowly, as many of its mature businesses are nearing or already experiencing secular decline.

By Nicholas Lieb, CFA

Quote time 2026-11-20 19:33:20 · For reference only, not investment advice and not tailored to your situation.

3M discussion 0 comments

Add a comment